Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 (COX-2) inhibitors (COXIBs) induce cancer cell apoptosis via several signaling pathways. There is evidence that they induce colon cancer cell apoptosis by suppressing peroxisome proliferator-activated receptor δ (PPARδ) through inhibition of COX-2-derived prostacyclin (PGI2). PGI2 activates PPARδ resulting in binding of PPARδ to specific PPAR response elements (PPRE) of target genes. We have identified 14-3-3ε as one of the genes that are upregulated by PPARδ. Elevated 14-3-3ε proteins in cytosol enhance sequestration of Bad and reduce mitochondrial damage by Bad and thereby control apoptosis. NSAIDs and COXIBs block PGI2 production, thereby reducing PPARδ DNA binding activity and abrogating 14-3-3e upregulation. Furthermore, the COX-2 inhibitors suppress PPARδ expression. Suppression of PPARδ leads to reduced 14-3-3e and hence a decline in Bad sequestration, resulting in an increased Bad-induced apoptosis via the mitochondrial death pathway.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith, W.L., Garavito, R.M., and DeWitt, D.L. (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)−1 and −2. J Biol Chem 271, 33157–60.
Vane, J.R., Mitchell, J.A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D.A. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 91, 2046–50.
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 91, 12013–7.
Gupta, R.A., and Dubois, R.N. (2001) Color-ectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1, 11–21.
Rhodes, J.M., and Campbell, B.J. (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8, 10–6.
Mantovani, A. (2007) Cancer: an infernal triangle. Nature 448, 547–8.
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R.N. (1998) Cycloox-ygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705–16. Erratum in: Cell 94, following 271.
Tsujii, M., Kawano, S., and DuBois, R.N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94, 3336–40.
Tsujii, M., and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostag-landin endoperoxide synthase 2. Cell 83, 493–501.
Liou, J.Y., Ghelani, D., Yeh, S., and Wu, K.K. (2007) Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε. Cancer Res 67, 3185–91.
Piazza, G.A., Rahm, A.L., Krutzsch, M., Sperl, G., Paranka, N.S., Gross, P.H., Brendel, K., Burt, R.W., Alberts, D.S., Pamukcu, R., et al. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55, 3110–6.
Shiff, S.J., Qiao, L., Tsai, L.L., and Rigas, B. (1995) Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96, 491–503.
Maier, T.J., Janssen, A., Schmidt, R., Geisslin-ger, G., and Grosch, S. (2005) Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-inde-pendent anticarcinogenic effects of celecoxib in human colon carcinoma cells. FASEB J 19, 1353–5.
Chiu, C.H., McEntee, M.F., and Whelan, J. (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res 57, 4267–73.
Grösch, S., Maier, T.J., Schiffmann, S., and Geisslinger, G. (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98, 736–47.
Hanif, R., Pittas, A., Feng, Y., Koutsos, M.I., Qiao, L., Staiano-Coico, L., Shiff, S.I., and Rigas, B. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Bio-chem Pharmacol 52, 237–45.
Castellone, M.D., Teramoto, H., Williams, B.O., Druey, K.M., and Gutkind, J.S. (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310, 1504–10.
Forman, B.M., Chen, J., and Evans, R.M. (1997) Hypolipidemic drugs, polyunsatu-rated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 94, 4312–7.
Liou, J.Y., Lee, S., Ghelani, D., Matijevic-Aleksic, N., and Wu, K.K. (2006) Protection of endothelial survival by peroxisome prolifer-ator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26, 1481–7.
Tan, N.S., Michalik, L., Noy, N., Yasmin, R., Pacot, C., Heim, M., Flühmann, B., Desvergne, B., and Wahli, W. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15, 3263–77.
Hao, C.M., Redha, R., Morrow, J., and Breyer, M.D. (2002) Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress. J Biol Chem 277, 21341–5.
Gupta, R.A., Tan, J., Krause, W.F., Geraci, M.W., Willson, T.M., Dey, S.K., and DuBois, R.N. (2000) Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci U S A 97, 13275–80.
He, T.C., Chan, T.A., Vogelstein, B., Kinzler, K.W. (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335–45.
Acknowledgments
This work was supported by grants from U.S. NIH (HL-50675), and Taiwan NHRI.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wu, K.K., Liou, JY. (2009). Cyclooxygenase Inhibitors Induce Colon Cancer Cell Apoptosis Via PPARδ → 14-3-3ε Pathway. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_16
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols